Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Transcutaneous immunization: a human vaccine delivery strategy using a patch.

G M Glenn1, D N Taylor, X Li

  • 1Department of Membrane Biochemistry, Walter Reed Army Institute of Research, 503 Robert Grant Rd., Rm. 2W-124, Silver Spring, Maryland 20910-7500, USA.

Nature Medicine
|December 2, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Waterborne transmission ofCampylobacter enteritis.

Microbial ecology·2013
Same author

Suppression of cytotoxicity of diphtheria toxin by monoclonal antibodies against phosphatidylinositol phosphate.

Biophysical journal·2009
Same author

BHD mutations, clinical and molecular genetic investigations of Birt-Hogg-Dubé syndrome: a new series of 50 families and a review of published reports.

Journal of medical genetics·2008
Same author

Immune response, ciprofloxacin activity, and gender differences after human experimental challenge by two strains of enterotoxigenic Escherichia coli.

Infection and immunity·2006
Same author

Mass vaccination: solutions in the skin.

Current topics in microbiology and immunology·2006
Same author

Fumarate hydratase enzyme activity in lymphoblastoid cells and fibroblasts of individuals in families with hereditary leiomyomatosis and renal cell cancer.

Journal of medical genetics·2006

Transcutaneous immunization (TCI) offers a needle-free vaccine delivery method targeting the skin. This study shows TCI using a heat-labile enterotoxin (LT) patch is safe and effective in humans, inducing strong antibody responses.

Area of Science:

  • Immunology
  • Vaccinology
  • Dermatology

Background:

  • Transcutaneous immunization (TCI) is a needle-free topical vaccine delivery method.
  • The skin's immune-rich environment is targeted for enhanced vaccine responses.
  • Previous animal studies demonstrated TCI's ability to induce robust systemic and mucosal antibodies.

Purpose of the Study:

  • To evaluate the safety and immunogenicity of TCI in humans.
  • To assess the induction of antibody responses against heat-labile enterotoxin (LT) using a TCI patch.
  • To explore the potential of TCI for improved vaccine delivery and efficacy in humans.

Main Methods:

  • Human subjects received a topical patch containing heat-labile enterotoxin (LT).
  • Safety of the TCI patch application was monitored.

Related Experiment Videos

  • LT-specific antibody responses were measured to assess immunogenicity.

    • Main Results:

    • Transcutaneous immunization with the LT-containing patch was demonstrated to be safe for human application.
    • Robust LT-antibody responses were successfully induced in human participants.
    • The study confirmed the feasibility of TCI for human immunization.

    Conclusions:

    • Transcutaneous immunization is a safe and feasible method for human vaccination.
    • TCI can elicit significant antibody responses, suggesting potential for enhanced vaccine efficacy.
    • This needle-free approach offers a promising alternative for vaccine delivery.